Definium Therapeutics (DFTX) Selling, General & Administrative (2021 - 2026)
Definium Therapeutics (DFTX) reported Selling, General & Administrative of $26.41 million for Q2 2026, up 138.1% from $11.09 million a year earlier and up 48.9% from the prior quarter.
Powered by 
Analysis
Definium Therapeutics (DFTX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Definium Therapeutics' Selling, General & Administrative came in at $72.9 million, up 90.8% year-over-year; for FY2025, it came in at $48.64 million, up 26.0% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $38.62 million in FY2024 (-7.5%), $41.74 million in FY2023 (+38.4%), $30.16 million in FY2022 (-48.9%) and $59.07 million in FY2021 (+310.2%).
- The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative since Q2 2021.
- Year over year, Selling, General & Administrative has now increased in each of the last five quarters, with growth averaging 44.0% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q2 2026 (growth of 138.1%); the low point was Q2 2022 (a decline of 79.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $17.74 million (Q1 2026), $14.06 million (Q4 2025) and $14.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Definium Therapeutics | 3.99 Bn | 1.91 Bn | - | 26.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.41 Mn |
| Mar 31, 2026 | 17.74 Mn |
| Dec 31, 2025 | 14.06 Mn |
| Sep 30, 2025 | 14.69 Mn |
| Jun 30, 2025 | 11.09 Mn |
| Mar 31, 2025 | 8.80 Mn |
| Dec 31, 2024 | 10.70 Mn |
| Sep 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 9.81 Mn |
| Mar 31, 2024 | 10.50 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Sep 30, 2023 | 8.41 Mn |
| Jun 30, 2023 | 14.41 Mn |
| Mar 31, 2023 | 8.26 Mn |
| Dec 31, 2022 | 5.07 Mn |
| Sep 30, 2022 | 9.21 Mn |
| Jun 30, 2022 | 7.62 Mn |
| Mar 31, 2022 | 8.26 Mn |
| Dec 31, 2021 | 6.68 Mn |
| Sep 30, 2021 | 8.21 Mn |
API Access
Definium Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DFTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();